Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

Autor: Xuan, Li *, Wang, Yu *, Yang, Kaibo *, Shao, Ruoyang *, Huang, Fen *, Fan, Zhiping, Chi, Peiru, Xu, Yajing, Xu, Na, Deng, Lan, Li, Xudong, Liang, Xinquan, Luo, Xiaodan, Shi, Pengcheng, Liu, Hui, Wang, Zhixiang, Jiang, Ling, Lin, Ren, Chen, Yan, Tu, Sanfang, Zhang, Yu, Sun, Jing, Huang, Xiaojun, Liu, Qifa *
Zdroj: In The Lancet Haematology August 2023 10(8):e600-e611
Databáze: ScienceDirect